Novartis India Ltd — Important, 04-06-2026: Company Update

Novartis India's Committee of Independent Directors (IDC) has shared its reasoned views on an open offer. A consortium including WaveRise Investments, ChrysCapital Fund X, and Two Infinity Partners aims to acquire up to 6,419,608 equity shares, representing 26% of the company's voting capital, at INR 860.64 per share. This IDC assessment, formed as per takeover regulations, provides important insights for public shareholders evaluating the open offer.